您当前所在的位置:首页 > 产品中心 > 产品信息
Gamma Hydroxybutyric Acid_分子结构_CAS_591-81-1)
点击图片或这里关闭

Gamma Hydroxybutyric Acid

产品号 DB01440 公司名称 DrugBank
CAS号 591-81-1 公司网站 http://www.ualberta.ca/
分子式 C4H8O3 电 话 (780) 492-3111
分子量 104.10452 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 1247

产品价格信息

请登录

产品别名

标题
Gamma Hydroxybutyric Acid
IUPAC标准名
4-hydroxybutanoic acid
IUPAC传统名
gamma-hydroxybutyric acid
商标名
Xyrem
别名
4-hydroxybutanoic acid
Juice
4-hydroxybutanoate
Sodium oxybate
gamma-Hydroxybutyric acid
GHB
4-Hydroxybutyric acid
4-Hydroxy-butanoic acid
Liquid Ecstasy

产品登记号

PubChem SID 46507548
PubChem CID 3037032
CAS号 591-81-1

产品性质

产品详细信息

详细说明 (English)
Item Information
Drug Groups illicit; approved
Description Gamma Hydroxybutyric Acid, commonly abbreviated GHB, is a therapeutic drug which is illegal in multiple countries. It is currently regulated in the US and sold by Jazz Pharmaceuticals under the name Xyrem. However, it is important to note that GHB is a designated Orphan drug (in 1985). Today Xyrem is a Schedule III drug;
however GHB remains a Schedule I drug and the illicit use of Xyrem falls under penalties of Schedule I. GHB is a naturally occurring substance found in the central nervous system, wine, beef, small citrus fruits and almost all other living creatures in small amounts. It is used illegally under the street names Juice, Liquid Ecstasy or simply G, either as an intoxicant, or as a date rape drug. Xyrem is a central nervous system depressant that reduces excessive daytime sleepiness and cataplexy in patients with narcolepsy.
Indication Used as a general anesthetic, to treat conditions such as insomnia, clinical depression, narcolepsy, and alcoholism, and to improve athletic performance.
Pharmacology GHB has at least two distinct binding sites in the central nervous system. GHB is an agonist at the newly-characterized GHB receptor, which is excitatory, and it is a weak agonist at the GABAB receptor, which is inhibitory. GHB is a naturally-occurring substance that acts in a similar fashion to some neurotransmitters in the mammalian brain. GHB is probably synthesized from GABA in GABAergic neurons, and released when the neurons fire.
Toxicity At higher doses, GHB may induce nausea, dizziness, drowsiness, agitation, visual disturbances, depressed breathing, amnesia, unconsciousness, and death.
Affected Organisms
Humans and other mammals
Half Life 30 to 60 minutes
Elimination Animal studies indicate that metabolism is the major elimination pathway for sodium oxybate, producing carbon dioxide and water via the tricarboxylic acid (Krebs) cycle and secondarily by beta-oxidation. Succinic acid enters the Krebs cycle where it is metabolized to carbon dioxide and water. Fecal and renal excretion is negligible.
5% renal elimination.
Distribution * 190 to 384 mL/kg
Clearance * apparent oral cl=9.1 mL/min/kg [healthy adults receiving a single oral dose of 25 mg/kg]
* 4.5 mL/min/kg [cirrhotic patients without ascites receiving a single oral dose of 25 mg/kg]
* 4.1 mL/min/kg [cirrhotic patients with ascites receiving a single oral dose of 25 mg/kg]
External Links
Wikipedia

参考文献